Fox Chase Cancer Center News

Fox Chase-Temple University Hospital Bone Marrow Transplant Program Awarded FACT Reaccreditation

PHILADELPHIA (February 8, 2017) – The Fox Chase-Temple University Hospital Bone Marrow Transplant Program has received internationally-recognized accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center for adult allogeneic and autologous hematopoietic progenitor cell transplantation, peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation. 

VIEW STORY

Most Elective Colorectal Surgery Patients Receive Inadequate Bowel Preparation to Prevent Postoperative Complications, Study Shows

PHILADELPHIA (February 2, 2017) – In the largest study of its kind to date, researchers from Fox Chase Cancer Center and the Lewis Katz School of Medicine at Temple University confirmed that oral antibiotics combined with mechanical bowel preparation were more effective at preventing surgical site infections after elective colorectal surgery compared to no bowel preparation or use of mechanical bowel preparation alone. Nestor F. Esnaola, MD, MPH, professor of surgical oncology at Fox Chase, led the study, which appears in Annals of Surgery.

VIEW STORY